cosibelimab
fortress,tg therapeutics,Checkpoint Therapeutics 
['cosibelimab', 'pivotal']
$ckpt checkpoint therapeutics announces presentation of pivotal trial results of cosibelimab at the 2022 american society of clinical oncology (asco) annual meeting 
News and analysis of biomedical, biopharma, biotech, biosciences, pharmaceutical, and technology equities